{"id":9264,"date":"2020-05-05T13:14:00","date_gmt":"2020-05-05T13:14:00","guid":{"rendered":"https:\/\/icrowdnewswire.com\/?p=2542048"},"modified":"2020-05-05T13:14:00","modified_gmt":"2020-05-05T13:14:00","slug":"menlo-therapeutics-to-report-first-quarter-2020-financial-results-on-may-11","status":"publish","type":"post","link":"https:\/\/ipsnews.net\/business\/2020\/05\/05\/menlo-therapeutics-to-report-first-quarter-2020-financial-results-on-may-11\/","title":{"rendered":"Menlo Therapeutics to Report First Quarter 2020 Financial Results on May 11"},"content":{"rendered":"<p align=\"left\">Menlo Therapeutics Inc.&nbsp; a specialty pharmaceutical company focused on developing and commercializing proprietary therapies to address unmet needs in dermatology, today announced that it will report its financial results for the first quarter ended March 31, 2020, on Monday, May 11, before the market opens. Menlo will host a conference call and webcast at 8:30 a.m. Eastern Time on Monday, May 11 to discuss the financial results and provide a corporate update.<\/p>\n<table class=\"gnw_table_border_collapse hugin\">\n<tbody>\n<tr>\n<td class=\"hugin\" colspan=\"3\"><em><strong>Conference Call &amp; Webcast<\/strong><\/em><\/td>\n<\/tr>\n<tr>\n<td class=\"hugin\" colspan=\"3\"><em><strong>Monday May 11th @ 8:30amET<\/strong><\/em><\/td>\n<\/tr>\n<tr>\n<td class=\"hugin\">Toll Free:<\/td>\n<td class=\"hugin\">&nbsp;<\/td>\n<td class=\"hugin\">877-407-0784<\/td>\n<\/tr>\n<tr>\n<td class=\"hugin\">International:<\/td>\n<td class=\"hugin\">&nbsp;<\/td>\n<td class=\"hugin\">201-689-8560<\/td>\n<\/tr>\n<tr>\n<td class=\"hugin\">Conference ID:<\/td>\n<td class=\"hugin\">&nbsp;<\/td>\n<td class=\"hugin\">13702832<\/td>\n<\/tr>\n<tr>\n<td class=\"hugin\">Webcast:<\/td>\n<td class=\"hugin\">&nbsp;<\/td>\n<td class=\"hugin\">http:\/\/public.viavid.com\/index.php?id=139512<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>A replay of the call will be archived on the Company&rsquo;s website at&nbsp;www.menlotherapeutics.com&nbsp;promptly after the conference call.<\/p>\n<p><strong>About Menlo Therapeutics<\/strong><br \/>Menlo Therapeutics Inc.&nbsp;recently combined with&nbsp;Foamix Pharmaceuticals Ltd.&nbsp;(&ldquo;Foamix&rdquo;) to form a different type of biopharmaceutical company working to solve some of today&rsquo;s most difficult therapeutic challenges in dermatology and beyond. Foamix is now a wholly-owned subsidiary of Menlo.<\/p>\n<p>With expertise in topical medicine innovation as a springboard, the Company is working to develop and commercialize a variety of solutions using its proprietary Molecule Stabilizing Technology (MST&trade;), and has received FDA approval for the world&rsquo;s first topical minocycline, AMZEEQ&trade; (minocycline) topical foam, 4%.<\/p>\n<p>For more information about Menlo or its investigational products, visit&nbsp;www.menlotherapeutics.com. Menlo may use its website to comply with its disclosure obligations under Regulation FD. Therefore, investors should monitor Menlo&rsquo;s website in addition to following its press releases, filings with the&nbsp;U.S. Securities and Exchange Commission, public conference calls, and webcasts.<\/p>\n<table class=\"gnw_table_border_collapse hugin\">\n<tbody>\n<tr>\n<td class=\"hugin\">&nbsp;<\/td>\n<td class=\"gnw_label_i30 hugin\">&nbsp;<\/td>\n<td class=\"hugin\">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td class=\"hugin\"><strong>Contact:&nbsp;<\/strong><br \/>Andrew Saik&nbsp;<br \/>Menlo Therapeutics<br \/>908-731-6180 &nbsp;<br \/>Andrew.Saik@foamix.com&nbsp; &nbsp;<\/td>\n<td class=\"hugin\">&nbsp;<\/td>\n<td class=\"hugin\"><strong>U.S. Investor Relations<\/strong><br \/>Joyce Allaire<br \/>LifeSci Advisors, LLC<br \/>646-889-1200<br \/>jallaire@lifesciadvisors.com&nbsp;<\/td>\n<\/tr>\n<tr>\n<td class=\"hugin\">&nbsp;<\/td>\n<td class=\"hugin\">&nbsp;<\/td>\n<td class=\"hugin\">&nbsp;<\/td>\n<\/tr>\n<tr>\n<td class=\"hugin\"><strong>Media:<\/strong><strong><br \/><\/strong>Vusi Moyo<br \/>Zeno Group<br \/>312-396-9703<br \/>vusi.moyo@zenogroup.com&nbsp;<\/td>\n<td class=\"hugin\">&nbsp;<\/td>\n<td class=\"hugin\">&nbsp;<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>&nbsp;<\/p>\n<div id=\"relatedarticles\">\n<div class=\"rel-articles\">&nbsp;<\/div>\n<\/div>\n<p class=\"tags\">\n<div><strong>See Campaign: <\/strong><a href=\"http:\/\/www.menlotherapeutics.com\" target=\"_blank\">http:\/\/www.menlotherapeutics.com<\/a><br \/><b>Contact Information:<\/b><br \/>Joyce Allaire<br \/>\nLifeSci Advisors, LLC<br \/>\n646-889-1200<br \/>\njallaire@lifesciadvisors.com<\/p>\n<p><b>Tags:<\/b><br \/><a href=\"\"><\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/news-category\/wire\/\" rel=\"category tag\">Wire<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/news-category\/disclosure-newswire\/\" rel=\"category tag\">Disclosure Newswire<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/global-regions\/united-states\/\" rel=\"category tag\">United States<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/language\/english\/\" rel=\"category tag\">English<\/a><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"\" alt=\"image\" width=\"400\" height=\"300\" class=\"cwdfimg\" \/><\/div>\n<div>\n<h3>Contact Information:<\/h3>\n<p>Joyce Allaire<br \/>\nLifeSci Advisors, LLC<br \/>\n646-889-1200<br \/>\njallaire@lifesciadvisors.com<\/p>\n<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Menlo Therapeutics Inc.&nbsp; a specialty pharmaceutical company focused on developing and commercializing proprietary therapies to address unmet needs in dermatology, today announced that it will report its financial results for the first quarter ended March 31, 2020, on Monday, May 11, before the market opens. Menlo will host a conference call and webcast at 8:30 &hellip; <a href=\"https:\/\/icrowdnewswire.com\/2020\/05\/05\/menlo-therapeutics-to-report-first-quarter-2020-financial-results-on-may-11\/\">Continue reading <span>Menlo Therapeutics to Report First Quarter 2020 Financial Results on May 11<\/span><\/a> <a href=\"https:\/\/ipsnews.net\/business\/2020\/05\/05\/menlo-therapeutics-to-report-first-quarter-2020-financial-results-on-may-11\/\" class=\"more-link\">Continue Reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":46,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[56,3,22,54],"tags":[],"class_list":["post-9264","post","type-post","status-publish","format-standard","hentry","category-disclosure-newswire","category-english","category-united-states","category-wire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Menlo Therapeutics to Report First Quarter 2020 Financial Results on May 11 - Business<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ipsnews.net\/business\/2020\/05\/05\/menlo-therapeutics-to-report-first-quarter-2020-financial-results-on-may-11\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Menlo Therapeutics to Report First Quarter 2020 Financial Results on May 11 - Business\" \/>\n<meta property=\"og:description\" content=\"Menlo Therapeutics Inc.&nbsp; a specialty pharmaceutical company focused on developing and commercializing proprietary therapies to address unmet needs in dermatology, today announced that it will report its financial results for the first quarter ended March 31, 2020, on Monday, May 11, before the market opens. Menlo will host a conference call and webcast at 8:30 &hellip; Continue reading Menlo Therapeutics to Report First Quarter 2020 Financial Results on May 11 Continue Reading &rarr;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ipsnews.net\/business\/2020\/05\/05\/menlo-therapeutics-to-report-first-quarter-2020-financial-results-on-may-11\/\" \/>\n<meta property=\"og:site_name\" content=\"Business\" \/>\n<meta property=\"article:published_time\" content=\"2020-05-05T13:14:00+00:00\" \/>\n<meta name=\"author\" content=\"Asiya\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Asiya\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ipsnews.net\/business\/2020\/05\/05\/menlo-therapeutics-to-report-first-quarter-2020-financial-results-on-may-11\/\",\"url\":\"https:\/\/ipsnews.net\/business\/2020\/05\/05\/menlo-therapeutics-to-report-first-quarter-2020-financial-results-on-may-11\/\",\"name\":\"Menlo Therapeutics to Report First Quarter 2020 Financial Results on May 11 - Business\",\"isPartOf\":{\"@id\":\"https:\/\/ipsnews.net\/business\/#website\"},\"datePublished\":\"2020-05-05T13:14:00+00:00\",\"author\":{\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/3a37b5ed16b9ebaf70290330c45a2e37\"},\"breadcrumb\":{\"@id\":\"https:\/\/ipsnews.net\/business\/2020\/05\/05\/menlo-therapeutics-to-report-first-quarter-2020-financial-results-on-may-11\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ipsnews.net\/business\/2020\/05\/05\/menlo-therapeutics-to-report-first-quarter-2020-financial-results-on-may-11\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ipsnews.net\/business\/2020\/05\/05\/menlo-therapeutics-to-report-first-quarter-2020-financial-results-on-may-11\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ipsnews.net\/business\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Menlo Therapeutics to Report First Quarter 2020 Financial Results on May 11\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ipsnews.net\/business\/#website\",\"url\":\"https:\/\/ipsnews.net\/business\/\",\"name\":\"Business\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ipsnews.net\/business\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/3a37b5ed16b9ebaf70290330c45a2e37\",\"name\":\"Asiya\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/d4d7dcc41e3f5a5cad4cf78eca935d2f4c65cc9a91e376789d357e29806bcb91?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/d4d7dcc41e3f5a5cad4cf78eca935d2f4c65cc9a91e376789d357e29806bcb91?s=96&d=mm&r=g\",\"caption\":\"Asiya\"},\"sameAs\":[\"https:\/\/icrowdnewswire.com\/fc\"],\"url\":\"https:\/\/ipsnews.net\/business\/author\/asiya\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Menlo Therapeutics to Report First Quarter 2020 Financial Results on May 11 - Business","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ipsnews.net\/business\/2020\/05\/05\/menlo-therapeutics-to-report-first-quarter-2020-financial-results-on-may-11\/","og_locale":"en_US","og_type":"article","og_title":"Menlo Therapeutics to Report First Quarter 2020 Financial Results on May 11 - Business","og_description":"Menlo Therapeutics Inc.&nbsp; a specialty pharmaceutical company focused on developing and commercializing proprietary therapies to address unmet needs in dermatology, today announced that it will report its financial results for the first quarter ended March 31, 2020, on Monday, May 11, before the market opens. Menlo will host a conference call and webcast at 8:30 &hellip; Continue reading Menlo Therapeutics to Report First Quarter 2020 Financial Results on May 11 Continue Reading &rarr;","og_url":"https:\/\/ipsnews.net\/business\/2020\/05\/05\/menlo-therapeutics-to-report-first-quarter-2020-financial-results-on-may-11\/","og_site_name":"Business","article_published_time":"2020-05-05T13:14:00+00:00","author":"Asiya","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Asiya","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ipsnews.net\/business\/2020\/05\/05\/menlo-therapeutics-to-report-first-quarter-2020-financial-results-on-may-11\/","url":"https:\/\/ipsnews.net\/business\/2020\/05\/05\/menlo-therapeutics-to-report-first-quarter-2020-financial-results-on-may-11\/","name":"Menlo Therapeutics to Report First Quarter 2020 Financial Results on May 11 - Business","isPartOf":{"@id":"https:\/\/ipsnews.net\/business\/#website"},"datePublished":"2020-05-05T13:14:00+00:00","author":{"@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/3a37b5ed16b9ebaf70290330c45a2e37"},"breadcrumb":{"@id":"https:\/\/ipsnews.net\/business\/2020\/05\/05\/menlo-therapeutics-to-report-first-quarter-2020-financial-results-on-may-11\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ipsnews.net\/business\/2020\/05\/05\/menlo-therapeutics-to-report-first-quarter-2020-financial-results-on-may-11\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ipsnews.net\/business\/2020\/05\/05\/menlo-therapeutics-to-report-first-quarter-2020-financial-results-on-may-11\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ipsnews.net\/business\/"},{"@type":"ListItem","position":2,"name":"Menlo Therapeutics to Report First Quarter 2020 Financial Results on May 11"}]},{"@type":"WebSite","@id":"https:\/\/ipsnews.net\/business\/#website","url":"https:\/\/ipsnews.net\/business\/","name":"Business","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ipsnews.net\/business\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/3a37b5ed16b9ebaf70290330c45a2e37","name":"Asiya","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/d4d7dcc41e3f5a5cad4cf78eca935d2f4c65cc9a91e376789d357e29806bcb91?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/d4d7dcc41e3f5a5cad4cf78eca935d2f4c65cc9a91e376789d357e29806bcb91?s=96&d=mm&r=g","caption":"Asiya"},"sameAs":["https:\/\/icrowdnewswire.com\/fc"],"url":"https:\/\/ipsnews.net\/business\/author\/asiya\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/9264","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/users\/46"}],"replies":[{"embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/comments?post=9264"}],"version-history":[{"count":1,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/9264\/revisions"}],"predecessor-version":[{"id":9265,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/9264\/revisions\/9265"}],"wp:attachment":[{"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/media?parent=9264"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/categories?post=9264"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/tags?post=9264"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}